Published in J Neurosurg on August 01, 2001
Light Scattering Spectroscopy to Determine Brain Tumors | NCT00067418
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med (2014) 9.19
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A (2008) 4.14
The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol (2014) 2.63
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy. Sci Transl Med (2013) 2.31
5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. Neurosurgery (2014) 2.23
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol (2008) 2.07
Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med (2009) 2.00
Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci U S A (2013) 1.95
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res (2009) 1.88
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. Br J Cancer (2007) 1.78
MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology (2013) 1.77
Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg (2012) 1.72
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol (2013) 1.63
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia (2007) 1.62
Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival. Surg Neurol Int (2010) 1.61
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol (2007) 1.59
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol (2013) 1.51
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol (2008) 1.48
Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth. Neuroimage (2009) 1.47
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. J Neurooncol (2008) 1.42
Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol (2011) 1.42
Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model. PLoS One (2015) 1.41
Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg (2013) 1.41
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol (2010) 1.40
Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study. World Neurosurg (2015) 1.39
Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol (2011) 1.37
Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification. J Cancer Res Clin Oncol (2015) 1.37
ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. J Neurosci (2009) 1.36
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res (2014) 1.35
The role of intraoperative magnetic resonance imaging in glioma surgery. Surg Neurol Int (2012) 1.33
The natural history of EGFR and EGFRvIII in glioblastoma patients. J Transl Med (2005) 1.33
Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol (2013) 1.31
Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection. Stereotact Funct Neurosurg (2009) 1.30
Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol (2009) 1.30
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer (2009) 1.30
GBM volumetry using the 3D Slicer medical image computing platform. Sci Rep (2013) 1.30
Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol (2012) 1.29
Review of Neurosurgical Fluorescence Imaging Methodologies. IEEE J Sel Top Quantum Electron (2010) 1.29
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol (2010) 1.25
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol (2013) 1.25
Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol (2010) 1.24
Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery. J Biomed Opt (2011) 1.23
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology (2014) 1.23
Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev (2014) 1.22
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia (2012) 1.22
Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics (2012) 1.20
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics (2009) 1.18
Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol (2009) 1.17
A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. Neoplasia (2010) 1.16
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol (2005) 1.16
Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery. J Neurooncol (2012) 1.15
Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis. Neuroradiology (2005) 1.15
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharm Res (2010) 1.13
Current data and strategy in glioblastoma multiforme. J Med Life (2010) 1.11
Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PLoS One (2012) 1.10
Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions. Singapore Med J (2016) 1.10
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells. Biomed Res Int (2014) 1.08
Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res (2007) 1.07
Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007. Spine (Phila Pa 1976) (2012) 1.07
Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol (2011) 1.07
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging (2010) 1.06
Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review). Exp Ther Med (2011) 1.05
Multi-modal glioblastoma segmentation: man versus machine. PLoS One (2014) 1.05
Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy. Clin Pharmacol Ther (2009) 1.05
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. Eur J Nucl Med Mol Imaging (2010) 1.05
Volumetric and MGMT parameters in glioblastoma patients: survival analysis. BMC Cancer (2012) 1.05
Evaluation of outcome and prognostic factors in patients of glioblastoma multiforme: A single institution experience. J Neurosci Rural Pract (2013) 1.04
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. BMC Cancer (2010) 1.04
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
The value of glioma extent of resection in the modern neurosurgical era. Front Neurol (2012) 1.02
Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol (2013) 1.02
Gliomas in adults. Dtsch Arztebl Int (2010) 1.02
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging (2004) 1.02
Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. J Neurooncol (2009) 1.02
Morphological characteristics of brain tumors causing seizures. Arch Neurol (2010) 1.01
Imaging of human brain tumor tissue by near-infrared laser coherence tomography. Acta Neurochir (Wien) (2009) 1.01
BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics (2014) 0.99
MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. J Exp Clin Cancer Res (2015) 0.99
Confocal laser endomicroscopy for diagnosis and histomorphologic imaging of brain tumors in vivo. PLoS One (2012) 0.99
Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. AJNR Am J Neuroradiol (2012) 0.99
Fiber tractography based on diffusion tensor imaging compared with high-angular-resolution diffusion imaging with compressed sensing: initial experience. Neurosurgery (2013) 0.99
Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography. Sci Transl Med (2015) 0.99
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. J Clin Oncol (2004) 0.98
Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clin Exp Metastasis (2012) 0.98
Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning. Eur J Nucl Med Mol Imaging (2012) 0.98
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status. Onco Targets Ther (2013) 0.97
Template-cut: a pattern-based segmentation paradigm. Sci Rep (2012) 0.97
Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS One (2013) 0.97
Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts. Oncotarget (2013) 0.96
Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas. BMC Clin Pathol (2005) 0.96
Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging. AJNR Am J Neuroradiol (2012) 0.95
Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution. Strahlenther Onkol (2011) 0.95
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Agriculture. Nutrient imbalances in agricultural development. Science (2009) 10.95
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science (1998) 7.32
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56
Consistent land- and atmosphere-based U.S. carbon sink estimates. Science (2001) 5.49
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40
Mapping striate and extrastriate visual areas in human cerebral cortex. Proc Natl Acad Sci U S A (1996) 4.69
The influence of patient-practitioner agreement on outcome of care. Am J Public Health (1981) 4.08
Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology (1998) 3.79
Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg (1996) 3.75
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol (1996) 3.50
Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg (1999) 3.32
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Type IV pilus of Myxococcus xanthus is a motility apparatus controlled by the frz chemosensory system. Curr Biol (2000) 3.24
Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res (1996) 3.23
Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum (2004) 3.12
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev (2000) 3.01
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol (2004) 2.95
SOS3 function in plant salt tolerance requires N-myristoylation and calcium binding. Plant Cell (2000) 2.91
Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs (2000) 2.82
Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med (1998) 2.82
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology (2000) 2.70
TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science (1999) 2.70
A 'pseudo-AIDS' syndrome following from fear of AIDS. Br J Psychiatry (1985) 2.69
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Psychological support and counselling for patients with acquired immune deficiency syndrome (AIDS). Genitourin Med (1985) 2.59
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55
The ars operon of Escherichia coli confers arsenical and antimonial resistance. J Bacteriol (1995) 2.52
Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology (2006) 2.52
HIV infection: increase in public awareness and anxiety. Br Med J (Clin Res Ed) (1987) 2.52
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Epidural versus continuous transversus abdominis plane catheter technique for postoperative analgesia after abdominal surgery. Anaesth Intensive Care (2013) 2.51
An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg (2000) 2.50
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology (2012) 2.50
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene (2006) 2.37
Induction of cyclin D1 overexpression by activated ras. Oncogene (1994) 2.35
Cerebral arteriovenous oxygen difference as an estimate of cerebral blood flow in comatose patients. J Neurosurg (1989) 2.32
Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery (1996) 2.30
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30
The changing spectrum of fungal keratitis in south Florida. Ophthalmology (1994) 2.29
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol (1999) 2.28
Aggressive meningeal tumors: review of a series. J Neurosurg (1995) 2.26
Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol (2001) 2.20
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity (2000) 2.16
Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med (1998) 2.15
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis (2013) 2.11
Occupational strain and the incidence of coronary heart disease. Am J Epidemiol (1989) 2.10
Fatalities during remission of childhood leukemia. Blood (1972) 2.08
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Breeding difficulties. Vet Rec (2001) 2.07
Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol (1996) 2.04
The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure (1998) 2.02
Functional magnetic resonance imaging (FMRI) of the human brain. J Neurosci Methods (1994) 2.02
Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest (2001) 2.01
Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis (2010) 1.98
Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene (2007) 1.98
Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med (2000) 1.95
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol (1999) 1.93
Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene (1999) 1.92
Why AIDS is not a notifiable disease. S Afr Med J (1992) 1.92
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science (1997) 1.92
Dimethylthetin can substitute for glycine betaine as an osmoprotectant molecule for Escherichia coli. J Bacteriol (1987) 1.91
A new set of chemotaxis homologues is essential for Myxococcus xanthus social motility. Mol Microbiol (1998) 1.91
Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology (2002) 1.89
The importance of radiating leg pain in assessing health outcomes among patients with low back pain. Results from the Veterans Health Study. Spine (Phila Pa 1976) (1998) 1.89
Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis. Biochemistry (2001) 1.86
Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry (2000) 1.83
Management of intracranial plasmacytoma. J Neurosurg (1995) 1.81
Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res (2000) 1.80
Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol (2001) 1.80
Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery (1999) 1.79
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Chronic and recovered cases of sheep-associated malignant catarrhal fever in cattle. Vet Rec (1997) 1.78
MinK-related peptide 1: A beta subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res (2001) 1.78
Adverse conditions which cause lack of flagella in Escherichia coli. J Bacteriol (1993) 1.76
Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology (2006) 1.75
Overexpression of transforming growth factor-beta1 in fetal monkey lung results in prenatal pulmonary fibrosis. Eur Respir J (2010) 1.75
Primary extradural meningiomas: a report on nine cases and review of the literature from the era of computerized tomography scanning. J Neurosurg (2000) 1.75
Imaging of perineural tumor spread from palatal carcinoma. AJNR Am J Neuroradiol (1998) 1.75
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol (2001) 1.74
Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol (1992) 1.72
The surgical treatment of metastatic spinal tumors within the intradural extramedullary compartment. J Neurosurg (1996) 1.71
Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med (1981) 1.71
Significance of C-terminal cysteine modifications to the biological activity of the Saccharomyces cerevisiae a-factor mating pheromone. Mol Cell Biol (1991) 1.70